About Babson Diagnostics
Babson Diagnostics is a company based in Austin (United States) founded in 2017 by Eric Olson.. Babson Diagnostics has raised $37.7 million across 2 funding rounds from investors including Siemens Healthineers, Emerald and Prism Venture Partners. Babson Diagnostics offers products and services including BetterWay Blood Testing. Babson Diagnostics operates in a competitive market with competitors including Tasso, YourBio Health, Velano Vascular, Weavr Health and Lo Biosciences, among others.
- Headquarter Austin, United States
- Founders Eric Olson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37.7 M (USD)
in 2 rounds
-
Latest Funding Round
$31 M (USD), Series B
Jun 29, 2021
-
Investors
Siemens Healthineers
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Babson Diagnostics
Babson Diagnostics offers a comprehensive portfolio of products and services, including BetterWay Blood Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers convenient blood testing with minimal sample for accurate results.
Unlock access to complete
Unlock access to complete
Funding Insights of Babson Diagnostics
Babson Diagnostics has successfully raised a total of $37.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $31.0M
-
First Round
First Round
(24 Sep 2020)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series B - Babson Diagnostics | Valuation | Emerald Development Managers | |
| Sep, 2020 | Amount | Series A - Babson Diagnostics | Valuation | Genesis Merchant Capital , Siemens Healthineers |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Babson Diagnostics
Babson Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Siemens Healthineers, Emerald and Prism Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Emerald.
|
Founded Year | Domain | Location | |
|
VC firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Babson Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Babson Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Babson Diagnostics Comparisons
Competitors of Babson Diagnostics
Babson Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tasso, YourBio Health, Velano Vascular, Weavr Health and Lo Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Blood collection devices for diagnostic applications are developed.
|
|
| domain | founded_year | HQ Location |
Push-button blood collection devices are manufactured for medical use.
|
|
| domain | founded_year | HQ Location |
Provider of a needle-free blood collection device
|
|
| domain | founded_year | HQ Location |
Manufactures high-quality blood collection devices for medical applications.
|
|
| domain | founded_year | HQ Location |
Developer of blood collection device
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Babson Diagnostics
Frequently Asked Questions about Babson Diagnostics
When was Babson Diagnostics founded?
Babson Diagnostics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Babson Diagnostics located?
Babson Diagnostics is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Who is the current CEO of Babson Diagnostics?
David Stein is the current CEO of Babson Diagnostics.
Is Babson Diagnostics a funded company?
Babson Diagnostics is a funded company, having raised a total of $37.7M across 2 funding rounds to date. The company's 1st funding round was a Series A of $6.7M, raised on Sep 24, 2020.
What does Babson Diagnostics do?
Provider of blood testing service using microsamples collected from a finger. It offers blood testing services, utilizing small blood samples obtained via finger-prick, aiming to make diagnostic testing more accessible. The offering focuses on delivering medically accurate results through a patient-centric approach. The goal is to facilitate regular diagnostic blood testing for early disease detection and informed healthcare decisions.
Who are the top competitors of Babson Diagnostics?
Babson Diagnostics's top competitors include YourBio Health, Tasso and Velano Vascular.
What products or services does Babson Diagnostics offer?
Babson Diagnostics offers BetterWay Blood Testing.
Who are Babson Diagnostics's investors?
Babson Diagnostics has 5 investors. Key investors include Siemens Healthineers, Emerald, Prism Venture Partners, LAGO Consulting & Services, and Genesis Merchant Capital.